Non-profit arm of the de-extinction company secures an additional $50 million, expands global projects and partnerships, and releases its inaugural Impact Report detailing progress in the fight ...

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7.8% in the afternoon session after the stock's ...

The FDA has been rumored to be evaluating whether or not to place a black box warning on vaccines for COVID-19.

The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership ...

Moderna MRNA announced that the Coalition for Epidemic Preparedness Innovations (“CEPI”) will invest up to $54.3 million in ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

CAMBRIDGE, MA / ACCESS Newswire / December 17, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced it will present at the 44th annual J.P. Morgan Healthcare Conference on Monday, January 12th at 7:30 p ...

Myocarditis has become a flashpoint in debates about COVID vaccines; however, new research suggests this rare heart ...

Moderna will get $54M from a global coalition for a bird flu mRNA vaccine after the US canceled a $760M deal and cut mRNA ...

Testing in mice suggests that rejuvenating T cells could make vaccines and some cancer therapies more effective.

The Coalition for Epidemic Preparedness Innovations said it will invest $54.3 million with Moderna to fund a Phase 3 trial of ...

Moderna will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental ...